Highlights
- Ramsay Health Care (ASX:RHC) reported AUD 18.6 billion in FY26 group revenue.
- Underlying group EBIT increased 11.8% in constant currency.
- Reported group NPAT after non-controlling interests reached AUD 329 million.
- Demerger documentation for Ramsay Santé was issued in October 2026.
Ramsay Health Care Limited operates hospitals, clinics and related healthcare services in Australia, the United Kingdom and Europe. During the November 16, 2026 trading session, Ramsay Health Care (ASX:RHC) traded at AUD 54.55, down 0.87%. Its FY26 accounts and October documents concerning a proposed Ramsay Santé demerger provide separate points of focus: performance of the hospital businesses and a potential change to the group’s structure.
Hospital Operations Across Several Regions
Ramsay Health Care (ASX:RHC) provides hospital and specialist healthcare services across different funding and regulatory systems. Its facilities depend on clinical staffing, patient demand, insurer and government funding arrangements, and the ability to use operating capacity effectively. Australian and UK businesses are discussed together in the company’s Funding Group reporting, while Europe includes operations associated with Ramsay Santé.
Hospital providers face a different operating model from medical technology manufacturers. Revenue is tied to episodes of care and contracted funding arrangements, while expenses include employees, medical supplies, facilities and capital investment. Capacity usage and treatment mix can affect the financial outcome even when patient activity increases.
FY26 Financial Performance
For the year ended June 30, 2026, Ramsay Health Care (ASX:RHC) reported group revenue from customers of AUD 18.6 billion, up 4.2% in constant currency. Australia recorded revenue growth of 8%, supported, according to the company, by higher use of facilities, changes in treatment complexity and improved revenue indexation.
Group underlying EBIT increased 11.8% in constant currency. Underlying net profit after tax after non-controlling interests increased 22.9% on the same basis. Ramsay reported group statutory net profit after tax and non-controlling interests of AUD 329 million. These measures differ in their treatment of underlying adjustments and therefore should not be presented interchangeably.
The Funding Group, consisting of Australia and the UK, recorded 12% growth in underlying EBIT and 17.9% growth in underlying net profit after tax after non-controlling interests, both in constant currency. Ramsay (ASX:RHC) attributed improved group operating performance to transformation efforts and efficiency initiatives across its regions.
Ramsay Santé Demerger Documents
In October 2026, Ramsay published a demerger booklet relating to the proposed distribution of shares in Ramsay Santé. Its investor calendar listed demerger meetings for November 24, 2026, alongside the annual general meeting. These published arrangements concern a proposed transaction rather than confirmation that the separation had already occurred by November 16.
A proposed demerger requires attention to the terms described in Shareholder materials and to the relevant approvals. Any changes in the group structure could also change the scope of future consolidated reporting. Ramsay Health Care (ASX:RHC) shareholders can refer to subsequent company announcements for verified outcomes, rather than assuming the proposal will proceed.
Risks and Near-Term Monitoring
Hospital operations face wage and staffing costs, insurance and government funding negotiations, shifts in patient Demand and the need for continuing Facility investment. Currency translation affects reported performance from overseas operations. Restructuring activity can introduce additional implementation and reporting complexity. Reporting on the Funding Group and European operations will help readers distinguish the performance of ongoing businesses from any accounting changes associated with a proposed separation.
The November 24 meetings identified in the investor calendar are a specific forthcoming milestone. Subsequent disclosures can be monitored for the demerger vote, the group’s operating performance, regional margins and progress on operational efficiency. The company’s next announcements will clarify the status of the proposed transaction.
Key Insights
FY26 featured higher constant-currency revenue, underlying EBIT and underlying profit, together with a proposed structural change involving Ramsay Santé. Financial performance and the outcome of the demerger process remain distinct matters for shareholders to monitor.






Please wait processing your request...